-
1Periodical
Source: Case reports in oncology. 14(1):279-283
-
2Academic Journal
Authors: Chevallier, Mathieu1 (AUTHOR), Kim, Floryane1 (AUTHOR), Friedlaender, Alex1,2 (AUTHOR), Addeo, Alfredo1 (AUTHOR) alfredo.addeo@hcuge.ch
Source: Clinical Medicine Insights: Oncology. 7/20/2023, p1-5. 5p.
Subject Terms: *MESOTHELIOMA, *CANCER chemotherapy, *IPILIMUMAB, *PLEURAL tumors, *NIVOLUMAB, *IMMUNOTHERAPY, *RARE diseases
-
3Academic Journal
Authors: Baer, Xavier1 (AUTHOR), Chevallier, Mathieu2 (AUTHOR), Rey Cobo, Juliana3 (AUTHOR), Plojoux, Jérôme3 (AUTHOR), De Vito, Claudio4 (AUTHOR), Addeo, Alfredo2 (AUTHOR)
Source: Case Reports in Oncology. 2024, Vol. 17 Issue 1, p549-555. 7p.
Subject Terms: *EPIDERMAL growth factor receptors, *LUNG cancer, *LUNG diseases, *SQUAMOUS cell carcinoma, *NON-small-cell lung carcinoma
-
4Academic Journal
Authors: Friedlaender, Alex, Tsantoulis, Petros, Chevallier, Mathieu, De Vito, Claudio, Addeo, Alfredo
Source: Frontiers in Oncology; 3/30/2021, Vol. 11, pN.PAG-N.PAG, 8p
-
5Academic Journal
Source: Cancer Genomics & Proteomics (1109-6535); Sep/Oct2020, Vol. 17 Issue 5, p597-603, 7p